Amgen Inc (AMGN) Receives a Hold from Citigroup

By Austin Angelo

Citigroup analyst Robyn Karnauskas maintained a Hold rating on Amgen Inc (AMGNResearch Report) today and set a price target of $210. The company’s shares opened today at $191.46.

According to TipRanks.com, Karnauskas is a 4-star analyst with an average return of 4.5% and a 48.3% success rate. Karnauskas covers the Healthcare sector, focusing on stocks such as Alexion Pharmaceuticals, Vertex Pharmaceuticals, and Biogen Inc.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amgen Inc with a $210.09 average price target.

See today’s analyst top recommended stocks >>

Amgen Inc’s market cap is currently $122.6B and has a P/E ratio of 51.02. The company has a Price to Book ratio of 8.55.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.